Show simple item record

dc.contributor.authorGray, Christen M.
dc.contributor.authorKatamba, Achilles
dc.contributor.authorNarang, Pratibha
dc.contributor.authorGiraldo, Jorge
dc.contributor.authorZamudio, Carlos
dc.contributor.authorJoloba, Moses
dc.contributor.authorNarang, Rahul
dc.contributor.authorParamasivan, C. N.
dc.contributor.authorHillemann, Doris
dc.contributor.authorNabeta, Pamela
dc.contributor.authorAmisano, Danielle
dc.contributor.authorAlland, David
dc.contributor.authorCobelens, Frank
dc.contributor.authorBoehme, Catharina C.
dc.date.accessioned2023-01-18T16:19:48Z
dc.date.available2023-01-18T16:19:48Z
dc.date.issued2016
dc.identifier.citationGray CM, Katamba A, Narang P, Giraldo J, Zamudio C, Joloba M, Narang R, Paramasivan CN, Hillemann D, Nabeta P, Amisano D, Alland D, Cobelens F, Boehme CC. 2016. Feasibility and operational performance of tuberculosis detection by loop-mediated isothermal amplification platform in decentralized settings: results from a multicenter study. J Clin Microbiol 54:1984 –1991. doi:10.1128/JCM.03036-15.en_US
dc.identifier.uri10.1128/JCM.03036-15.
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/7032
dc.description.abstractCurrently available nucleic acid amplification platforms for tuberculosis (TB) detection are not designed to be simple or inexpensive enough to implement in decentralized settings in countries with a high burden of disease. The loop-mediated isothermal amplification platform (LAMP) may change this. We conducted a study in adults with symptoms suggestive of TB in India, Uganda, and Peru to establish the feasibility of using TB-LAMP (Eiken Chemical Co.) in microscopy laboratories compared with using smear microscopy against a reference standard of solid and liquid cultures. Operational characteristics were evaluated as well. A total of 1,777 participants met the eligibility criteria and were included for analysis. Overall, TB-LAMP sensitivities among culture-positive samples were 97.2% (243/250; 95% confidence interval [CI], 94.3% to 98.2%) and 62.0% (88/142; 95% CI, 53.5% to 70.0%) for smear-positive and smear-negative TB, respectively, but varied widely by country and operator. Specificities ranged from 94.5% (446/472; 95% CI, 92.0% to 96.4%) to 98.0% (350/357; 95% CI, 96.0% to 99.2%) by country. A root cause analysis identified high temperatures, high humidity, and/or low reaction volumes as possible causes for false-positive results, as they may result in nonspecific amplification. The study was repeated in India with training focused on vulnerable steps and an updated protocol; 580 participants were included for analysis. Specificity in the repeat trial was 96.6% (515/533; 95% CI, 94.7% to 97.9%). To achieve acceptable performance of LAMP at the microscopy center level, significant training and infrastructure requirements are necessary.en_US
dc.language.isoenen_US
dc.publisherJournal of Clinical Microbiologyen_US
dc.subjectFeasibilityen_US
dc.subjectTuberculosis Detectionen_US
dc.subjectIsothermal Amplification Platformen_US
dc.subjectDecentralized Settingsen_US
dc.titleFeasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record